As the Head of the Global Life Sciences Business Unit at SAS, Susan Lenderts provides executive leadership and partners with customers to enable meaningful impact in the Life Sciences Industry through analytics, innovation and digital transformation. Lenderts’ mission is to bring the full power of SAS to the life sciences industry to unlock business value and drive business strategy and decision making, ultimately helping organizations to develop, market and distribute safe and effective therapeutics to the patients who need them. Lenderts has spent nearly two decades in the life sciences industry with roles spanning clinical research through to commercial and strategic operations leadership at Quintiles (now IQVIA), Innoviva, ViiV Healthcare (GSK) and her own advisory firm. She holds a bachelor’s degree in economics and political science from the University of Notre Dame and a master’s degree in business administration from the University of North Carolina Chapel Hill, Kenan-Flagler Business School.
The platforms we choose don't just shape how data flows. They shape how people work. In clinical analytics, those decisions affect far more than technology. And in clinical development, a platform that only works for part of your team isn't a technology problem. It's a leadership problem and one every
If you asked health care and life sciences leaders, they would resoundingly say that the convergence of the industries is top of mind. Lita Sands, Managing Director at Deloitte, confirmed that this is a pivotal movement that can drive significant improvements in patient care and operational efficiencies. On a recent
